Ginsenoside F1

Ginsenoside F1, an enzymatically modified derivative of ginsenoside Rg1, protection from ultraviolet-B-induced apoptosis is tightly correlated with ginsenoside-F1-mediated inhibition of ultraviolet-B-induced downregulation of Bcl-2 and Brn-3a expression. Ginsenoside F1 exhibited competitive inhibition of the activity of CYP3A4 with Ki values of 57.7 ± 9.6 μM and 67.8 ± 16.2 μM, respectively. Ginsenoside F1 exhibited a weaker inhibition of the activity of CYP2D6.

Product Specifications

CAS Number

53963-43-2

Purity

>98% (HPLC)

Solubility

Soluble in Pyridine, Methanol, Ethanol, etc.

Smiles

CC (=CCC[C@@] (C) ([C@H]1CC[C@@]2 ([C@@H]1[C@@H] (C[C@H]3[C@]2 (C[C@@H] ([C@@H]4[C@@]3 (CC[C@@H] (C4 (C) C) O) C) O) C) O) C) O[C@H]5[C@@H] ([C@H] ([C@@H] ([C@H] (O5) CO) O) O) O) C